Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma
This study is currently recruiting participants.
Verified December 2012 by National Institutes of Health Clinical Center (CC)
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )
ClinicalTrials.gov Identifier:
NCT00942877
First received: July 18, 2009
Last updated: May 14, 2013
Last verified: December 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | July 2016 |
| Estimated Primary Completion Date: | July 2014 (Final data collection date for primary outcome measure) |